Deccan Health Care Limited has submitted a regulatory filing to the Listing Compliance Department of BSE Limited regarding an upcoming board meeting.
The meeting of the Board of Directors is scheduled to be held on Friday, 14th August 2026. The primary agenda item is to consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30th, 2026 (Q1 FY2027).
The company has complied with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 29, for this intimation.
Regarding insider trading protocols, the company had previously intimated via letter dated June 25, 2026, that the trading window for dealing in the company's securities was closed for Designated Persons, their immediate relatives, and Insiders of the Company. The closure began on July 01, 2026. The trading window will reopen 48 hours after the declaration of the Financial Results.
The document is signed by Shikha Das, Company Secretary & Compliance Officer (Membership Number A78917).